From figure it was observed that DT contains a potent ability to inhibit protein denaturation, inhibit bacterial growth on solid media and radical scavenging activity. However, the values decreased significantly in case of DT entrapped micelles but the values again increased after the release of DT at lower pH from the micellized core. Hence, it can be postulated that DT is the primary contributor of the bioactivity of the micellized formulation in both cases. Without the release of DT the micelles could not inflict the bioactivity properly because the entrapped DT could not get released. However, due to better sensitivity as observed in the liquid media system, B. subtilis showed better inhibition zone diameter than E. coli. Hence, this substantiates the pH responsive nature of the formulation, where the drug release and its further action can only occur after attaining the favourable stimuli which is low pH in this case. Moreover, none of the formulations exhibited any significant haemolytic activity (<5%) and protein denaturation property and these results validate the non-aggressive nature of the micelle-based formulations. Ergo, the serum protein denaturation inhibition experiment demonstrated that the DT-loaded micelles had no substantial adverse or inflammatory effects, owing to their benign characteristics. Hence, from all results it can be said that the DT loaded micelles possess biocompatible profile and retains necessary characteristics to be used as oral formulations.